Literature DB >> 23594935

Rapid on-site evaluation improves needle aspiration sensitivity in the diagnosis of central lung cancers: a randomized trial.

Michele Mondoni1, Paolo Carlucci, Fabiano Di Marco, Stefania Rossi, Pierachille Santus, Alice D'Adda, Giuseppe Francesco Sferrazza Papa, Gaetano Bulfamante, Stefano Centanni.   

Abstract

BACKGROUND: Few prospective studies have evaluated the role of endobronchial needle aspiration in diagnosing central airways neoplasms. Rapid on-site evaluation has long been used in transbronchial needle aspiration of adenopathies and peripheral lesions, but its role in sampling central malignancies has not been substantiated yet.
OBJECTIVES: In this study we evaluated if endobronchial needle aspiration may increase the sensitivity of bronchoscopy for diagnosing central airways neoplasms when added to conventional diagnostic methods (forceps biopsy, brushing and bronchial washing), and if rapid on-site evaluation may be beneficial in patients undergoing endobronchial needle aspiration.
METHODS: 125 patients (77% males, aged 70 ± 7 years; mean ± SD) with central lung cancers were randomized to undergo bronchoscopy including conventional diagnostic methods and needle aspiration, with or without rapid on-site evaluation, stratifying the patients on the basis of the neoplasm growth pattern (exophytic and submucosal/peribronchial disease).
RESULTS: Needle aspiration significantly increased the sensitivity of bronchoscopy when added to conventional methods (from 76 to 91%; p < 0.001), primarily resulting from differences in submucosal/peribronchial diseases (68 vs. 90%; p < 0.001) and independently from the presence of rapid on-site evaluation; needle aspiration guided by rapid on-site evaluation guaranteed a higher improvement in bronchoscopy sensitivity than conventional needle aspiration (98 vs. 84%, respectively; p = 0.004). Needle aspiration guided by rapid on-site evaluation showed a significantly higher sensitivity than the conventional method (97 vs. 76%, respectively; p = 0.001).
CONCLUSIONS: Needle aspiration increases the sensitivity of bronchoscopy in diagnosing central airways malignancies when added to conventional diagnostic methods, with a further significant improvement when guided by rapid on-site evaluation.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23594935     DOI: 10.1159/000346998

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis.

Authors:  Xiao-Cen Zhang; Quan-Lin Li; Yong-Fu Yu; Li-Qing Yao; Mei-Dong Xu; Yi-Qun Zhang; Yun-Shi Zhong; Wei-Feng Chen; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2015-08-27       Impact factor: 4.584

2.  Multi-modal tissue sampling in cone beam CT guided navigation bronchoscopy: comparative accuracy of different sampling tools and rapid on-site evaluation of cytopathology.

Authors:  Roel L J Verhoeven; Shoko Vos; Erik H F M van der Heijden
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

3.  Efficacy of rapid on-site evaluation for diagnosing pulmonary lesions and mediastinal lymph nodes: a systematic review and meta-analysis.

Authors:  Xi Chen; Bing Wan; Yangyang Xu; Yong Song; Ping Zhan; Litang Huang; Hongbing Liu; Dang Lin; Tangfeng Lv
Journal:  Transl Lung Cancer Res       Date:  2019-12

4.  Endobronchial ultrasound versus conventional transbronchial needle aspiration in the diagnosis of mediastinal lymphadenopathy: a meta-analysis.

Authors:  Jun-Hong Yan; Lei Pan; Xiao-Li Chen; Jian-Wei Chen; Li-Ming Yan; Bao Liu; Yong-Zhong Guo
Journal:  Springerplus       Date:  2016-10-05

5.  Endobronchial Ultrasound-guided Transbronchial Needle Aspiration versus Standard Bronchoscopic Modalities for Diagnosis of Sarcoidosis: A Meta-analysis.

Authors:  Li-Xing Hu; Ru-Xuan Chen; Hui Huang; Chi Shao; Ping Wang; Yong-Zhe Liu; Zuo-Jun Xu
Journal:  Chin Med J (Engl)       Date:  2016-07-05       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.